TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,919 | -22.8% | 1,934 | -21.6% | 0.00% | – |
| Q2 2023 | $38,741 | +24.1% | 2,466 | +30.1% | 0.00% | – |
| Q1 2023 | $31,230 | +39.0% | 1,895 | +31.6% | 0.00% | – |
| Q4 2022 | $22,464 | +2.1% | 1,440 | -14.1% | 0.00% | – |
| Q3 2022 | $22,000 | +46.7% | 1,677 | +61.4% | 0.00% | – |
| Q2 2022 | $15,000 | +66.7% | 1,039 | +56.7% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 663 | -8.9% | 0.00% | – |
| Q4 2021 | $10,000 | -61.5% | 728 | -54.7% | 0.00% | – |
| Q3 2021 | $26,000 | -18.8% | 1,606 | -15.0% | 0.00% | – |
| Q2 2021 | $32,000 | -78.5% | 1,889 | -76.9% | 0.00% | -100.0% |
| Q1 2021 | $149,000 | +1.4% | 8,167 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $147,000 | -5.2% | 8,080 | -7.0% | 0.00% | 0.0% |
| Q3 2020 | $155,000 | -5.5% | 8,686 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | -1.8% | 9,146 | -17.0% | 0.00% | 0.0% |
| Q1 2020 | $167,000 | -13.9% | 11,017 | +12.1% | 0.00% | 0.0% |
| Q4 2019 | $194,000 | +21.2% | 9,829 | +5.5% | 0.00% | 0.0% |
| Q3 2019 | $160,000 | -22.7% | 9,320 | -20.4% | 0.00% | 0.0% |
| Q2 2019 | $207,000 | -31.0% | 11,707 | -20.5% | 0.00% | -50.0% |
| Q1 2019 | $300,000 | +29900.0% | 14,725 | +33365.9% | 0.00% | – |
| Q4 2018 | $1,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |